Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry

Aim. Catheter ablation (CA) is an effective approach for rhythm control in atrial fibrillation (AF), however antiarrhythmic therapy (AAT) remains important. There is a lack of data about long-term AAT use after CA. This study evaluates AAT after CA for AF.Material and methods. In 2012-2016, EURObser...

Full description

Bibliographic Details
Main Authors: L. E. Korobchenko, S. A. Bayramova, V. E. Kharats, O. N. Kachalkova, A. Yu. Dmitriev, R. E. Batalov, D. P. Morgunov, I. A. Silin, A. A. Aleksandrovskiy, D. V. Kryzhanovskiy, A. B. Romanov, E. A. Pokushalov, D. S. Lebedev, V. A. Kuznetsov, G. V. Kolunin, D. A. Zamanov, S. Yu. Chetverikov, S. M. Yashin, S. V. Popov, E. A. Ivanitsky, A. I. Gorkov, S. E. Mamchur, V. A. Bazaev, E. N. Mikhaylov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2020-06-01
Series:Российский кардиологический журнал
Subjects:
atrial fibrillation
antiarrhythmic therapy
registry
catheter ablation
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3874

Internet

https://russjcardiol.elpub.ru/jour/article/view/3874

Similar Items